Motley Fool Australia

Telix Pharmaceuticals Ltd (ASX: TLX) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Telix Pharmaceuticals Ltd (ASX: TLX) Latest News

red arrow pointing down, falling share price

Why Ampol, Flight Centre, Syrah, & Telix shares are dropping lower

More »

graph of paper plane trending down

Why the Telix (ASX:TLX) share price is dropping lower today

More »

asx growth shares

How the Telix (ASX:TLX) share price roared over 150% in a year

More »

changing asx share price from acqusition represented by man reaching out to touch acquisition sign

Telix (ASX:TLX) share price down 4% despite new deal

More »

close up of man's eye looking through magnifying glass representing asx 200 share price on watch

The Telix (ASX:TLX) share price is on the move today. Here’s why.

More »

medical research

Telix (ASX:TLX) share price slips despite priority review status

More »

share price higher

Why Flight Centre, Fortescue, Kogan, & Telix shares are racing higher

More »

Investor riding a rocket blasting off over a share price chart

Why has the Telix (ASX:TXL) share price shot up 5% today?

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
02 Nov 2020 Oliver Buck Buy 165 $140,530
02 Nov 2020 Oliver Buck Exercise 165 $140,530
12 May 2020 Christian Behrenbruch Issued 200 $294,000
27 Feb 2020 Mark Nelson Buy 400 $580,000
13 Feb 2020 Oliver Buck Buy 164 $140,110
13 Feb 2020 Oliver Buck Exercise 164 $140,110


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Harry Kevin McCann Non-Executive Chairman,Non-Executive Director Sep 2017
Ms Jann E Skinner Non-Executive Director Jun 2018
Dr Christian Peter Behrenbruch Chief Executive Officer,Managing Director Jan 2017
Dr Andreas Kluge Executive Director,Chief Medical Officer Jan 2017
Mr Oliver Buck Non-Executive Director Jan 2017
Dr Mark Alexander Nelson Non-Executive Director Sep 2017
Ms Melanie Farris Company Secretary Mar 2017
David Cade Chief Business Officer & Head of Investor Relations
Melanie Farris Company Secretary
Ros Wilson Global Head of Drug Development
Douglas Cubbin Group Chief Financial Officer
Gabriel Liberatore Group Chief Operating Officer
Melanie Farris Group Secretary & Head of Corporate Governance Chief People Officer
Ludovic Wouters President, Telix Europe (Interim)
Shintaro Nishimura President, Telix Japan
Bernard Lambert President, Telix USA
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 32,489,522 12.83%
Elk River Holdings Pty Ltd 24,675,000 9.74%
Gnosis Verwaltungsgesellschaftm B H 24,675,000 9.74%
BNP Paribas Noms Pty Ltd 9,406,521 3.71%
Dale Ltd 7,995,600 3.16%
J P Morgan Nominees Australia Pty Limited 7,515,730 2.97%
The Oncidium Foundation 6,719,898 2.65%
Citicorp Nominees Pty Limited 4,841,331 1.91%
Uv Cap Gmbh & Co Kg 4,700,000 1.86%
UBS Nominees Pty Ltd 4,277,983 1.69%
Jean-Marc Le Doussal 3,901,554 1.54%
BNP Paribas Nominees Pty Ltd 3,845,417 1.52%
HSBC Custody Nominees (Australia) Limited A/C 2 3,425,710 1.35%
Uv-Cap Gmbh & Co 3,075,000 1.21%
National Nominees Limited 2,941,405 1.16%
Remora Capital 2,613,163 1.03%
Ilusa Sprl 2,558,138 1.01%
Yelwac Pty Ltd 2,381,804 0.94%
Cyclotek Pty Ltd 2,350,000 0.93%
Sargon Ct Pty Ltd 2,242,500 0.89%
Man Holdings Pty Ltd 2,238,750 0.88%
Show more